Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Apple
AAPL
|
$3.93B |
| 2 |
EOG Resources
EOG
|
$1.64B |
| 3 |
Amazon
AMZN
|
$1.32B |
| 4 |
Gilead Sciences
GILD
|
$1.23B |
| 5 |
Amgen
AMGN
|
$1.21B |
Top Sells
| 1 |
AGN
ALLERGAN INC
AGN
|
$2.33B |
| 2 |
United Parcel Service
UPS
|
$1.28B |
| 3 |
CVS Health
CVS
|
$1.01B |
| 4 |
Capital One
COF
|
$963M |
| 5 |
HP
HPQ
|
$955M |
Sector Composition
| 1 | Healthcare | 20.19% |
| 2 | Technology | 12.85% |
| 3 | Industrials | 11.43% |
| 4 | Communication Services | 10.57% |
| 5 | Energy | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Analog Devices
ADI
$124B
| $232M | 0.08% | 4,299,826 | – | – |
|
202
Norfolk Southern
NSC
$62.8B
| $230M | 0.08% | 2,233,800 +515,000 | +30% | +$53.1M |
|
203
Herbalife
HLF
$1.01B
| $230M | 0.08% | +3,560,335 | New | +$230M |
|
204
Grifois
GRFS
$6.78B
| $229M | 0.08% | 5,195,945 | – | – |
|
205
TJX Companies
TJX
$152B
| $229M | 0.08% | 4,300,000 +700,000 | +19% | +$37.2M |
|
206
Knowles
KN
$1.83B
| $228M | 0.08% | 7,423,609 +4,880,276 | +192% | +$150M |
|
207
Novartis
NVS
$245B
| $228M | 0.08% | 2,515,056 +58,000 | +2% | +$5.25M |
|
208
Freeport-McMoran
FCX
$63.7B
| $226M | 0.08% | 6,200,000 | – | – |
|
209
Revvity
RVTY
$10.5B
| $218M | 0.08% | 4,649,000 +2,380,000 | +105% | +$111M |
|
210
Jacobs Solutions
J
$17.5B
| $217M | 0.08% | 4,080,000 | – | – |
|
211
Chart Industries
GTLS
$8.96B
| $217M | 0.08% | 2,625,600 +179,000 | +7% | +$14.8M |
|
|
DNY
212
DELISTED
DONNELLEY R R & SONS CO
DNY
| $216M | 0.08% | 12,753,412 +4,897,455 | +62% | +$83.1M |
|
|
SIX
213
DELISTED
Six Flags Entertainment Corp.
SIX
| $215M | 0.08% | 5,061,993 +3,868,493 | +324% | +$165M |
|
|
SIVB
214
DELISTED
SVB Financial Group
SIVB
| $215M | 0.08% | 1,843,800 +47,800 | +3% | +$5.57M |
|
215
John Wiley & Sons Class A
WLY
$2.16B
| $213M | 0.07% | 3,520,683 | – | – |
|
216
Visa
V
$683B
| $211M | 0.07% | 1,000,000 | – | – |
|
217
Plains GP Holdings
PAGP
$3.82B
| $210M | 0.07% | 6,570,000 | – | – |
|
|
SBNY
218
DELISTED
Signature Bank
SBNY
| $209M | 0.07% | 1,654,559 | – | – |
|
|
MWV
219
DELISTED
MEADWESTVACO CORP
MWV
| $207M | 0.07% | 4,667,890 -3,520,690 | -43% | -$156M |
|
220
Equity Residential
EQR
$25.3B
| $205M | 0.07% | 3,250,500 | – | – |
|
221
United Airlines
UAL
$34B
| $203M | 0.07% | 4,951,596 -3,471,773 | -41% | -$143M |
|
|
GWPH
222
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $200M | 0.07% | 1,863,100 +1,054,600 | +130% | +$113M |
|
223
IDEX
IEX
$12.4B
| $196M | 0.07% | +2,432,000 | New | +$196M |
|
224
HSBC
HSBC
$224B
| $195M | 0.07% | 3,848,165 | – | – |
|
225
BP
BP
$90.8B
| $195M | 0.07% | 3,693,500 -620,500 | -14% | -$32.7M |
|